Aptevo Therapeutics - 48 Year Dividend History | APVO

Historical dividend payout and yield for Aptevo Therapeutics (APVO) since 1971. The current TTM dividend payout for Aptevo Therapeutics (APVO) as of May 17, 2019 is $0.00. The current dividend yield for Aptevo Therapeutics as of May 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.036B $0.023B
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $103.634B 11.72
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.478B 51.02